Correlation between serum free fatty acids levels and Gensini score in elderly patients with coronary heart disease. 2014

Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
Department of Cardiology, Peking University Third Hospital and Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing 100191, China.

OBJECTIVE To investigate the relationship between serum free fatty acids (FFAs) levels and the severity of coronary artery lesions in elderly patients with coronary heart disease (CAD). METHODS A total of 172 elderly patients who underwent coronary angiography were divided into CAD group (n = 128) and non-CAD group (n = 44) according to the results of coronary angiography. Serum FFAs and lipid levels were measured and the Gensini score were calculated. RESULTS No matter the differences between age, gender and the usage of statins or not, there was no statistical significance in FFAs levels (P > 0.05). In terms of the Gensini score, it was higher in patients aged 70-79 years than in patients 60-69 years old [15.00 (5.00, 34.00) vs. 10.00 (2.00, 24.00), P < 0.05], higher in men than women [14.00 (4.00, 34.00) vs. 7.00 (2.50, 19.75), P < 0.05], and higher in patients on statins [13.50 (4.25, 33.50) vs. 6.50 (2.00, 18.00), P < 0.05]. The serum FFAs levels [449.50 (299.00, 624.75) mEq/L vs. 388.00 (258.50, 495.25) mEq/L, P < 0.05] and Gensini score [17.50 (8.00, 41.75) vs. 1.00 (0, 5.00), P < 0.05] were higher in the CAD group than in the non-CAD group. In the CAD group, there was no statistical significance in FFAs levels among patients with different numbers of diseased coronary vessels (P > 0.05). Furthermore, the FFAs levels were positively correlated with the Gensini score (r = 0.394, P = 0.005). Regression analysis showed that the FFAs levels were related to the Gensini score independently after adjusting for the other risk factors. CONCLUSIONS The serum FFAs levels were associated with the Gensini score in elderly patients with CAD. It might indicate FFAs as a biomarker predicting the severity of coronary artery lesions.

UI MeSH Term Description Entries

Related Publications

Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
December 2023, The heart surgery forum,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
January 2019, Cardiology,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
February 2019, Cureus,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
January 2008, Clinical interventions in aging,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
June 2014, Irish journal of medical science,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
May 2011, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
January 2015, International journal of clinical and experimental medicine,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
August 2011, The American journal of cardiology,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
November 1973, Metabolism: clinical and experimental,
Li-Yun He, and Jun-Feng Zhao, and Jiang-Li Han, and Shan-Shan Shen, and Xu-Jiao Chen
February 2013, Zhonghua yi xue za zhi,
Copied contents to your clipboard!